High ROIC Stocks
NNNN is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
ANBIO BIOTECHNOLOGY LTD (NNNN) Stock Price & Overview
NASDAQ:NNNN • KYG0367B1059
Current stock price
25.85 USD
+0.14 (+0.54%)
Last:
The current stock price of NNNN is 25.85 USD. Today NNNN is up by 0.54%. In the past month the price increased by 18.58%. In the past year, price increased by 258.03%.
NNNN Key Statistics
52-Week Range5.89 - 55.65
Current NNNN stock price positioned within its 52-week range.
1-Month Range20.1 - 27.49
Current NNNN stock price positioned within its 1-month range.
- Market Cap
- 1.135B
- P/E
- 184.64
- Fwd P/E
- N/A
- EPS (TTM)
- 0.14
- Dividend Yield
- N/A
NNNN Stock Performance
Today
+0.54%
1 Week
+11.42%
1 Month
+18.58%
3 Months
-12.31%
Longer-term
6 Months -19.62%
1 Year +258.03%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
NNNN Stock Chart
NNNN Stock Screens
NNNN currently appears in the following ChartMill screener lists.
NNNN Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to NNNN. When comparing the yearly performance of all stocks, NNNN is one of the better performing stocks in the market, outperforming 96.76% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
NNNN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to NNNN. While NNNN has a great health rating, its profitability is only average at the moment.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NNNN Earnings
Next Earnings DateApr 27, 2026
Last Earnings DateN/A
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
NNNN Forecast & Estimates
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
NNNN Groups
Sector & Classification
NNNN Financial Highlights
Over the last trailing twelve months NNNN reported a non-GAAP Earnings per Share(EPS) of 0.14. The EPS increased by 47.03% compared to the year before.
Income Statements
Revenue(TTM)12.77M
Net Income(TTM)5.97M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 42.53% | ||
| ROA | 31.55% | ||
| ROE | 34.72% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%6.72%
Sales Q2Q%-21.63%
EPS 1Y (TTM)47.03%
Revenue 1Y (TTM)1.66%
NNNN Ownership
Ownership
Inst Owners4.85%
Shares43.89M
Float41.79M
Ins OwnersN/A
Short Float %0.09%
Short Ratio0.58
NNNN Competitors/Peers
The largest stocks on the US markets in the "Biotechnology" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 369.265B | ||
| AMGN | AMGEN INC | 15.24 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 11.03 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.53 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NNNN
Company Profile
Anbio Biotechnology is a medical device company. The company is headquartered in Frankfurt, Hessen and currently employs 27 full-time employees. The company went IPO on 2025-02-19. The firm is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
Company Info
IPO: 2025-02-19
ANBIO BIOTECHNOLOGY LTD
Friedrich-Ebert-Anlage 49
Frankfurt HESSEN DE
Employees: 27
Phone: 4916096247281
ANBIO BIOTECHNOLOGY LTD / NNNN FAQ
Can you describe the business of ANBIO BIOTECHNOLOGY LTD?
Anbio Biotechnology is a medical device company. The company is headquartered in Frankfurt, Hessen and currently employs 27 full-time employees. The company went IPO on 2025-02-19. The firm is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
What is the current price of NNNN stock?
The current stock price of NNNN is 25.85 USD. The price increased by 0.54% in the last trading session.
Does NNNN stock pay dividends?
NNNN does not pay a dividend.
What is the ChartMill rating of ANBIO BIOTECHNOLOGY LTD stock?
NNNN has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Should I buy NNNN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NNNN.